Skip to main content
. 2024 Sep 13;38(12):814–820. doi: 10.1038/s41371-024-00956-9

Table 1.

Clinical characteristics of participants.

Variable Group 1 Group 2
Age (years) 8.1 ± 4.1 15.6 ± 2.6**
Sex (female) 8 (62) 15 (44)
Height (cm) 124.1 ± 26.8 165.4 ± 13.5**
Weight (kg) 32.3 ± 25.1 59.0 ± 17.1**
Body surface area (m2) 1.0 ± 0.5 1.6 ± 0.3*
Arm circumference (cm) 20.4 ± 5.6 25.4 ± 3.9**
Heart rate (bpm) 80 ± 9 70 ± 11*
Brachial systolic pressure (mmHg) 91.6 ± 11.1 115.9 ± 12.1**
Brachial diastolic pressure (mmHg) 48.4 ± 8.4 65.6 ± 6.2**
ASD/PDA/PFO/VSD 7 (47) 7 (21)
Transposition of the Great Arteries 3 (20) 7 (21)
Tetralogy of Fallot 0 (0) 9 (27)
Controls (normal, healthy participants) 0 (0) 6 (18)
Coarctation of the Aorta 0 (0) 4 (12)
Pre-Fontan (BCPC) 4 (27) 0 (0)
Cardiomyopathy 1 (7) 2 (6)
Pulmonary atresia 0 (0) 3 (9)
Fontan 2 (13) 0 (0)
Pulmonary artery stenosis 0 (0) 2 (6)
Transplant (CM) 1 (7) 0 (0)

Data presented as mean ± standard deviation or n (%). Some participants had more than one condition; therefore, the tally of cardiac conditions is greater than the number of participants. There are 15 participants in Group 1 and 34 participants in Group 2. Three participants did not have an arm circumference recorded (therefore n = 46 for this comparison). The ‘Controls’ group refers to participants without a history of cardiac surgery and who were screened but found to have normal cardiac and vascular anatomy and function. The ‘Cardiomyopathy’ group refers to the following conditions: constrictive pericarditis; arrhythmogenic right ventricular cardiomyopathy; and myocarditis.

ASD atrial septal defect, PDA patent ductus arteriosus, PFO patent foramen ovale, VSD ventricular septal defect, BCPC bi-directional cavo-pulmonary connection, CM cardiomyopathy.

*p = 0.01 and **p ≤ 0.001 when Groups 1 and 2 were compared.